Načítá se...
Nanoparticle vaccines against respiratory syncytial virus
Respiratory syncytial virus (RSV) is a leading cause of respiratory disease in infants, the elderly and immunocompromised individuals. Despite the global burden, there is no licensed vaccine for RSV. Recent advances in the use of nanoparticle technology have provided new opportunities to address som...
Uloženo v:
| Vydáno v: | Future Virol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Future Medicine Ltd
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7737143/ https://ncbi.nlm.nih.gov/pubmed/33343684 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fvl-2020-0174 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|